News Article

French healthcare ecosystem and pharmacy retail group Hygie31 has completed the acquisition of CentralFarma, giving the French health giant a robust foothold in the Spanish market, a significant moment in the group’s strategic expansion across Europe.

CentralFarma brings a network of 230 pharmacies into the Hygie31 ecosystem, providing an immediate and substantial presence in a key geographic region. This move follows a period of rapid inorganic growth for Hygie31, which saw the group acquire nearly 350 pharmacies in 2023 alone after receiving backing from Latour Capital and Bpifrance.

The deal demonstrates the accelerating consolidation of the European pharmacy sector through integrated service models. Hygie31 operates by establishing sophisticated contractual relationships with member pharmacies, providing centralised support for human resources, accounting, and purchasing. This structure allows the group to capture value through service fees and operational efficiencies while navigating the complex regulatory environments that often restrict direct equity ownership in individual pharmacies.

By integrating CentralFarma, Hygie31 is scaling its ability to offer these centralised management services across international borders, creating a more resilient and diversified revenue stream.

The acquisition also highlights the evolving financial architecture of the healthcare industry. While direct investment in pharmacy equity is often governed by strict professional independence rules, groups like Hygie31 use innovative financial arrangements to provide support and capture growth. This includes the use of bond issuances and debt funds that can eventually convert into equity or are secured against pharmacy assets.

For the broader market, this deal signals that the traditional, fragmented pharmacy model is being replaced by large-scale platforms that leverage data and centralised procurement to drive profitability. As Hygie31 continues to build its European health platform, this Spanish entry serves as a blueprint for how operators can achieve cross-border scale while maintaining the operational independence of local healthcare professionals.